Furthermore, the expression level of miR-126, located in the introns of EGFR like-domain, is low in GBM patients and the deletion of miR-34a in GBM correlates with amplified EGFR in vivo and in vitro [51,55]. The gene discussed is EGFR; the disease is glioblastoma.